Zelatriazin
Zelatriazin (TAK-041; NBI-1065846) is a potent and selective GPR139 agonist with an EC50 of 22 nM. Zelatriazin has the potential for the research of negative symptoms associated with schizophrenia[1].
Product Specifications
CAS Number
1929519-13-0
Product Name Alternative
TAK-041; NBI-1065846
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
GPR139
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/zelatriazin.html
Concentration
10mM
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N[C@H](C1=CC=C(OC(F)(F)F)C=C1)C)CN2N=NC3=CC=CC=C3C2=O
Molecular Formula
C18H15F3N4O3
Molecular Weight
392.33
Precautions
H315, H319, H335
References & Citations
[1]Reichard HA, et al. Discovery of TAK-041: a Potent and Selective GPR139 Agonist Explored for the Treatment of Negative Symptoms Associated with Schizophrenia [published online ahead of print, 2021 Jul 14]. J Med Chem. 2021;10.1021/acs.jmedchem.1c00820.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K3172102 1.0 µg DNA
Lrrc9 sgRNA CRISPR Lentivector (Mouse) (Target 1)
Sign In for Pricing
View Details 
GTR15311161 1 Vial
Lentiviral human RAD51C shRNA (UAS) - Lentiviral human RAD51C shRNA (UAS, GFP) plasmid
Sign In for Pricing
View Details